|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/36 | (2006.01) | ||
| C12N 5/12 | (2006.01) |
| (11) | Number of the document | 1054693 |
| (13) | Kind of document | T |
| (96) | European patent application number | 99909512.8 |
| Date of filing the European patent application | 1999-02-19 | |
| (97) | Date of publication of the European application | 2000-11-29 |
| (45) | Date of publication and mention of the grant of the patent | 2008-10-29 |
| (46) | Date of publication of the claims translation | 2009-03-25 |
| (86) | Number | PCT/US1999/003566 |
| Date | 1999-02-19 |
| (87) | Number | WO 1999/042133 |
| Date | 1999-08-26 |
| (30) | Number | Date | Country code |
| 75328 P | 1998-02-20 | US |
| (72) |
FUNG, Michael, S., C., US
SUN, Cecily, R., Y., US
SUN, Bill, N., C., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Komplemento aktyvacijos inhibitoriai |
| INHIBITORS OF COMPLEMENT ACTIVATION |
| Payment date | Validity (years) | Amount | |
| 2018-01-31 | 20 | 347.00 EUR |